308 related articles for article (PubMed ID: 17984815)
1. Nevirapine-associated rash with eosinophilia and systemic symptoms in a child with human immunodeficiency virus infection.
Santos RP; Ramilo O; Barton T
Pediatr Infect Dis J; 2007 Nov; 26(11):1053-6. PubMed ID: 17984815
[TBL] [Abstract][Full Text] [Related]
2. DRESS (drug rash with eosinophilia and systemic symptoms) syndrome associated with nevirapine therapy.
Bourezane Y; Salard D; Hoen B; Vandel S; Drobacheff C; Laurent R
Clin Infect Dis; 1998 Nov; 27(5):1321-2. PubMed ID: 9827291
[No Abstract] [Full Text] [Related]
3. Case reports: treatment of nevirapine-associated dress syndrome with intravenous immune globulin (IVIG).
Fields KS; Petersen MJ; Chiao E; Tristani-Firouzi P
J Drugs Dermatol; 2005; 4(4):510-3. PubMed ID: 16004028
[TBL] [Abstract][Full Text] [Related]
4. Nevirapine-associated rash in a Jamaican child with HIV/AIDS.
Steel-Duncan JC; Pierre R; Gabay L; Christie CD
West Indian Med J; 2004 Oct; 53(5):356-8. PubMed ID: 15675504
[TBL] [Abstract][Full Text] [Related]
5. Desensitization to Nevirapine.
TreatmentUpdate; 1999 Nov; 11(8):5. PubMed ID: 11367044
[TBL] [Abstract][Full Text] [Related]
6. Hypersensitivity syndrome (DRESS) and meningoencephalitis associated with nevirapine therapy.
Lanzafame M; Rovere P; De Checchi G; Trevenzoli M; Turazzini M; Parrinello A
Scand J Infect Dis; 2001; 33(6):475-6. PubMed ID: 11450872
[TBL] [Abstract][Full Text] [Related]
7. Nevirapine hypersensitivity.
Popovic M; Shenton JM; Chen J; Baban A; Tharmanathan T; Mannargudi B; Abdulla D; Uetrecht JP
Handb Exp Pharmacol; 2010; (196):437-51. PubMed ID: 20020271
[TBL] [Abstract][Full Text] [Related]
8. HLA-Cw8 primarily associated with hypersensitivity to nevirapine.
Gatanaga H; Yazaki H; Tanuma J; Honda M; Genka I; Teruya K; Tachikawa N; Kikuchi Y; Oka S
AIDS; 2007 Jan; 21(2):264-5. PubMed ID: 17197830
[No Abstract] [Full Text] [Related]
9. Gender difference in Nevirapine-associated rash.
Proj Inf Perspect; 1999 Apr; (27):11. PubMed ID: 11366728
[TBL] [Abstract][Full Text] [Related]
10. Nevirapine-induced rash with eosinophilia and systemic symptoms (DRESS).
Gill S; Sagar A; Shankar S; Nair V
Indian J Pharmacol; 2013; 45(4):401-2. PubMed ID: 24014920
[TBL] [Abstract][Full Text] [Related]
11. [Cutaneous, hepatic and hematologic manifestations due to nevirapine: DRESS syndrome?].
Sissoko D; Ajana F; de la Tribonnière X; Baclet V; Mouton Y
Presse Med; 2000 May 27-Jun 3; 29(19):1041-2. PubMed ID: 10874910
[TBL] [Abstract][Full Text] [Related]
12. Severe hepatotoxicity associated with nevirapine use in HIV-infected subjects.
Sanne I; Mommeja-Marin H; Hinkle J; Bartlett JA; Lederman MM; Maartens G; Wakeford C; Shaw A; Quinn J; Gish RG; Rousseau F
J Infect Dis; 2005 Mar; 191(6):825-9. PubMed ID: 15717255
[TBL] [Abstract][Full Text] [Related]
13. Assessment of cetirizine, an antihistamine, to prevent cutaneous reactions to nevirapine therapy: results of the viramune-zyrtec double-blind, placebo-controlled trial.
Launay O; Roudière L; Boukli N; Dupont B; Prévoteau du Clary F; Patey O; David F; Lortholary O; Devidas A; Piketty C; Rey E; Urbinelli R; Allaert FA; Tréluyer JM; Caumes E;
Clin Infect Dis; 2004 Apr; 38(8):e66-72. PubMed ID: 15095233
[TBL] [Abstract][Full Text] [Related]
14. Oral adverse effects due to the use of Nevirapine.
Moura MD; Senna MI; Madureira DF; Fonseca LM; Mesquita RA
J Contemp Dent Pract; 2008 Jan; 9(1):84-90. PubMed ID: 18176653
[TBL] [Abstract][Full Text] [Related]
15. Nevirapine-related adverse events in a patient receiving a fixed-drug combination pill.
Daniel OJ; Krain AB; Ogun SA; Odusoga OL; Boyle BA
J Natl Med Assoc; 2005 Dec; 97(12):1719-21. PubMed ID: 16396066
[TBL] [Abstract][Full Text] [Related]
16. Is nevirapine-based therapy discontinuation in hepatitis C co-infected patients a more important mortality determinant than hypersensitivity.
Raffi F; Lewden C; Chêne G
AIDS; 2008 Jan; 22(3):435-6. PubMed ID: 18195573
[No Abstract] [Full Text] [Related]
17. [Combined antiretroviral therapy with nevirapine of HIV-infected adults].
Kravchenko AV
Ter Arkh; 2004; 76(11):68-71. PubMed ID: 15658542
[No Abstract] [Full Text] [Related]
18. [Antiretroviral-induced toxiderma in HIV-infected patients].
Caumes E; Bossi P; Katlama C; Bricaire F
Presse Med; 2003 Sep; 32(28):1325-33. PubMed ID: 14506444
[TBL] [Abstract][Full Text] [Related]
19. Optimal treatment of nevirapine-associated hepatotoxicity remains uncertain.
Bundow D; Rosoff L; Aboulafia DM
AIDS Read; 2001 Nov; 11(11):577-80. PubMed ID: 11789021
[TBL] [Abstract][Full Text] [Related]
20. Severe hepatic failure related to nevirapine treatment.
Cattelan AM; Erne E; Salatino A; Trevenzoli M; Carretta G; Meneghetti F; Cadrobbi P
Clin Infect Dis; 1999 Aug; 29(2):455-6. PubMed ID: 10476768
[No Abstract] [Full Text] [Related]
[Next] [New Search]
